Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences

Overview of attention for article published in BMC Health Services Research, January 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 46 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing : D: Pharmacological treatment

Cited by National Institute for Health and Care Excellence on 19 May 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing : G: Economic modelling report on pharmacological treatment

Cited by National Institute for Health and Care Excellence on 24 Mar 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.